Company intelligence / Profile preview

American Pacific

Cedar City, Utah, USA

Ownership: Private
Employees: ~140
Development stage: Other

Overview

AFC (Ampac Fine Chemicals) was a recognized supplier of APIs and registered intermediates, including supplying intermediates for Tamiflu/oseltamivir for Roche, and APIs for approved oncology products. The company operated cGMP facilities and niche platforms in chiral separations, potent compounds, and energetic chemistry.

Therapeutic areas: OncologyInfectious DiseasesEndocrinologyNeurology
Modalities: Small moleculeActive pharmaceutical ingredientRegistered intermediateCytotoxic compoundsNucleoside analogChiral compounds (via SMB)
Industry: Contract Manufacturing Organization

Partnerships

Roche (production partner for Tamiflu)

Beyond the preview

Go deeper on American Pacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Pacific.

Explore the full profile